Narsoplimab (OMS721), a Masp-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA)

Authors :: Olaf Penack
Nelson Leung
Michael Scordo
Mehdi Hamadani
Alessandro Rambaldi
Jaap Jan Boelens
Rafael F. Duarte
Sebastian Mayer
Miguel-Angel Perales
Sergio Giralt
Samer K. Khaled
Wlodzimierz Mendrek
Jeffery C Laurence
Vincent T. Ho
Jameela Sathar
Mitchell S. Cairo
Richard E. Champlin
Sumithira Vasu
Source :: Transplantation and Cellular Therapy. 27:S24-S26
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Transplantation
Thrombotic microangiopathy
medicine.anatomical_structure
business.industry
medicine
Cancer research
Molecular Medicine
Immunology and Allergy
Hematopoietic stem cell
Cell Biology
Hematology
medicine.disease
business

Full Text Access

Tools